Metraipolis › archive › dc_c52f233fadaf

JMT103 versus Non-Denosumab or Denosumab Treatment in Chinese Patients with Unresectable or Surgically Challenging Giant Cell Tumor of Bone: A Propensity… — Europe PMC PMID:41292259

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41292259
DOI
10.1002/cam4.71340
License (as archived)
solo-consultazione
Archived
2026-11-08T21:24:51.929Z
SHA-256 of the archived text
1f71df07a4faee2afc2f1ec0971e9b03dff617afb366db909cf27aaf327ea771
Stable URL of this page
https://metraipolis.com/documento/dc_c52f233fadaf

How to cite

JMT103 versus Non-Denosumab or Denosumab Treatment in Chinese Patients with Unresectable or Surgically Challenging Giant Cell Tumor of Bone: A Propensity… — Europe PMC PMID:41292259 — Europe PMC (en), https://europepmc.org/article/MED/41292259 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c52f233fadaf (Metraipolis archive dc_c52f233fadaf, sha256 1f71df07a4faee2afc2f1ec0971e9b03dff617afb366db909cf27aaf327ea771)
BibTeX
@misc{dcc52f233fadaf,
  title = {JMT103 versus Non-Denosumab or Denosumab Treatment in Chinese Patients with Unresectable or Surgically Challenging Giant Cell Tumor of Bone: A Propensity… — Europe PMC PMID:41292259},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41292259},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c52f233fadaf; sha256 1f71df07a4faee2afc2f1ec0971e9b03dff617afb366db909cf27aaf327ea771},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41292259. Agents can read the archived copy with the MCP tool read_document.